American cutaneous leishmaniasis (ACL) is an endemic disease in Northern
in the country (Sosa-Estani et al. 1998) . At present, the characterization of parasites from human patients in Tucumán has not been possible. Studies from epidemic outbreaks in nearby provinces within Argentina, indicate that the parasites belong to the L. braziliensis complex (Campanini et al. 1993 , Cuba et al. 1996 , Sosa-Estani et al. 1998 . The presence of L. (L.) amazonensis (L. mexicana complex) by isoenzymatic analysis has also been reported in the Chaco region, Argentina (Frank et al. 2000) .
The most common diagnostic method for cutaneous leishmaniasis used in Argentina is the smear -histopathology exam in combination with clinical and epidemiological data. Mucocutaneous leishmaniasis generally requires a complementary test because of the scarcity of parasites in the lesions.
The polymerase chain reaction technique (PCR) has been successfully employed in the detection of specific sequences of pathogenic agents (Erlich 1991) . At present this technique is an adequate method for the leishmaniasis diagnosis, showing a high sensitivity when compared to traditional tests (Rodgers et al. 1990 , De Bruijn & Barker 1992 , De Bruyin et al. 1993 , Lopez et al. 1993a , b, Meredith et al. 1993 , Piarroux et al. 1994 . The sensitivity of the laboratory diagnosis increases significantly when PCR is combined with Southern blotting (Andresen et al. 1996) .
In the present study we used PCR and Southern blotting for the detection of Leishmania spp. and identification of the parasite from skin biopsies, histologically examined, of human patients from an endemic area of Tucumán province, Argentina.
MATERIALS AND METHODS
Samples -In this study we used 22 paraffin-embedded skin biopsies from endemic areas of leishmaniasis in the province of Tucumán, kindly donated by the Pathologic Anatomy Service of the Angel C Padilla Hospital (Tucumán, Argentina). Twenty one of the samples had a clinical diagnosis for leishmaniasis and the histopathology test was positive for 13 of them and negative for the rest (Table I ). The only sample with a nonleishmanial clinical diagnosis and a negative histopathology result was that used as a negative control.
DNA extraction -For each sample five to seven 5 µm sections of paraffin-embedded tissue were placed in a tube. The samples were washed with xilene, incubated for 30 min at 37ºC, centrifuged at 13,000 rpm for 5 min and the supernatant discarded. The washing procedure was repeated three times. Then two washes with ethanol 100% were performed followed by two final washes with PBS (NaCl 0.14 M, KCl 2.68 mM, Na 2 HPO 4 0.01 M, KH 2 PO 4 1.76 mM, pH 7.4). The resulting pellet was resuspended in a 100 µl of Proteinase-K lysis buffer (Tris-HCl 10 mM, pH 8.5, EDTA 10 mM and 4 µl of Proteinase-K (20 mg/ml). The samples were incubated at 60ºC for 2 h. Then the enzyme was inactivated for 5 min at 95ºC and the samples rapidly centrifuged. Two µl of the supernatants of each sample were used for the PCR reaction (modified from Wright & Manos 1990) .
PCR procedure -The primers used to detect Leishmania spp. were previously designed (Fernandes et al. 1994) . Briefly, the PCR reaction mixture (50 µl total volume) consisted of PCR buffer 1X (10mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 ) (Perkin-Elmer), 2.5 U/µl of Taq DNA polymerase (Perkin-Elmer), 200 µM of each deoxynucleoside triphosphate (dNTPs) (Pharmacia), 15 pmol of each primer, and 2 µl of the DNA sample. In this reaction DNA amplification was performed for a first cycle at 94ºC for 5 min of incubation, 30 cycles at 94ºC for 30 s, 50ºC for 30 s and 72ºC for 30 s with a final extension cycle of 10 min at 72ºC. In the case of specific DNA amplification of the L. braziliensis and L. mexicana complexes we used the oligonucleotide primers B1/B2 (De Bruijn & Barker 1992) and M1/M2 (Eresh et al. 1994) respectively. The reaction mixture consisted of 5 µl of PCR buffer (1X), 8 µl of dNTPs, 0.5 µl of each primer (20 pmol/µl), 2 µl de DNA (10 ng/µl), 0.5 µl de Taq DNA polymerase (2.5 U/µl) and 33.5 µl of ultrapure water. DNA amplification was performed for 35 cycles using previously established conditions (De Bruijn & Barker 1992 , Eresh et al. 1994 . For the detection of L. (V.) braziliensis DNA we used the primers L14-A /L14-C (Alonso 1999) . The PCR reaction mixture (50 µl total volume) consisted of PCR buffer 1X (10mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 ) (Perkin-Elmer), 2.5 U/µl of Taq DNA polymerase (Perkin-Elmer), 200 µM of each deoxynucleoside triphosphate (dNTPs) (Pharmacia), 15 pmol of each primer, and 2 µl of the DNA sample. DNA amplification was performed by a first cycle at 94°C for 3 min of incubation, followed by 30 cycles at 94°C for 1 min, 58°C for 1 min and 72°C for 1:30 min, with a final extension PCR products were analyzed on a 1.5% agarose gel, stained with ethidium bromide and visualized under UV light. All products were transferred to a nylon membrane using a southern blot procedure according to standard conditions (Sambrook et al. 1989) . Two PCR amplified minicircle kDNA fragments from L. (V.) braziliensis strain (MHOM/PE/95/LQ2) and L. (L.) amazonensis strain (MHOM/77/LTB0016) were used as probes in different reactions. The amplified products were isolated from an agarose gel and purified by the Quiaex II gel extraction Kit (Quiagen). Twenty five ng of each purified fragment were labelled with digoxigenin coupled to dUTP (deoxyuracile triphosphate) using the DIG DNA Labeling Kit (Boehringer Mannhein). The blot was prehibrydized at 68ºC for 2 h in SSC 5X (sodium chloride 0.15 M, trisodium citrate 0.015 M), sodium dodecyl sulphate (SDS) 0.02%, N-lauroylsarcosine, blocking reagent 2% (Roche). Hybridization with the specific labelled probe L. (V.) braziliensis or L. (L.) amazonensis (25 ng), depending on the reaction, was performed at 68ºC overnight. Washing conditions were 2 × 5 min in SSC 2X, SDS 0.1% at room temperature and 2×15 min in SSC 0.1X, SDS 0.1% at 68ºC. The hybridized products were immunodetected with anti-digoxigenin-AP, Fag fragments and then visualized with the colorimetric substrates NBT/BCIP using the DIG Nucleic Acid Detection Kit (Roche).
RESULTS
From all of the samples with a clinical diagnosis of leishmaniasis DNA amplification with genus-specific primers was positive in 19 of them. The amplified Leishmaniaspecific fragment (120 bp) corresponds to the amplification of a minicircle sequence of the kDNA. These results were confirmed by the Southern blot-hybridization of the PCR products with the specific L. (V.) braziliensis probe (Fig. 1) .
The entire samples positive for cutaneous leishmaniasis by histopathology were also positive with the PCR hybridization combined technique. Leishmania DNA was detected in 6 of the 8 samples that showed a negative diagnosis of leishmaniasis when assessed histopathology. It is noteworthy that one of these 6 samples belonged to a clinically cured patient (Table) .
The only sample with nonleishmanial clinical features, used as a negative control, showed negative results when analysed by both methods, i.e., histopathology and PCRhybridization.
Overall PCR-hybridization showed a sensitivity of 90.5 %, whilst for the histopathology test was 61.9%.
The second step was to determine more precisely the parasite present in the 19 positive samples for Leishmania spp.
Firstly, we performed a PCR using primers specific for the L. braziliensis and L. mexicana complexes followed by a hybridization assay. The amplified products obtained showed a 760 bp fragment in the positive samples in both cases. From all the samples analyzed we were able to de- tect in 5 of them the parasite as belonging to the L. braziliensis complex (Fig. 2) . We did not detect any L. mexicana complex parasite in the samples. Secondly, the 19 samples positive by the PCR Leishmania specific were analysed with a PCR specific for the species L. (V.) braziliensis. A 160 bp fragment was amplified in 4 of the samples. This result was confirmed with a Southern blot and hybridization with a specific probe for L. (V.) braziliensis.
There was only one positive sample detected by both PCR-hybridization experiments, i.e., the one using B1/B2 specific primers for the L. braziliensis complex and the one using L14-A/L14-C specific primers for the species L. (V.) braziliensis. Detection of L. braziliensis by PCR • Elizabeth Córdoba Lanús et al.
DISCUSSION
This study reveals that L. (V.) braziliensis was the causal agent of leishmaniasis in the human samples analyzed using a PCR-hybridization assay.
The results presented here demonstrate that the leishmanial etiology was established in 61.9% by the conventional method and in 90.5% by PCR-hybridization. No false positive results were obtained. Laskay et al. (1995) , using oligonucleotide primers 13A and 13B were able to detect L. aethiopica in paraffin-embedded tissue, in 7 out of the 22 cases where the conventional methods failed. They proposed the PCR as a valid diagnostic method for leishmaniasis, especially for chronic cases of the pathology. Furthermore, Medeiros et al. (2002) using the same primers found positivity in 81.5% of the examined samples by PCR, with a specificity of 100%, while the histological test was positive in 50% of the cases. Safei et al. (2002) found a sensitivity of 92% in the diagnosis of cutaneous leishmaniasis in paraffin-embedded biopsies using PCR, and a specificity of 100%.
The PCR combined with Southern blotting can increment the sensitivity of the method. Andresen et al. (1996) reached a 93% of positives using this combination when compared to the results obtained by PCR when used alone (86%) in contrast with the sensitivity detected by histopathology (76%).
Five of the total samples analysed by the complex specific primers B1/B2 (De Bruijn & Barker 1992) were positive for the L. braziliensis complex.
Furthermore, the PCR using the primers L14-A and L14-C (Alonso 1999) specific for L. (V.) braziliensis, which amplify the sequence of the ribosomal protein L14 of this species (Gonzalez et al. 2004) , detected the parasite in 4 samples, only one of them was also amplified by the PCR specific for the L. braziliensis complex.
The oligonucleotides B1/B2 used in this assay are capable of detecting 1 fg of purified DNA, equivalent to about 1000 kDNA minicircles of 760 bp. This method was evaluated using a diversity of crude DNA samples: human biopsies and lymph aspirates; sand flies samples and biopsies from wild animals (De Bruijn & Barker 1992) . De Bruijn et al. (1993) in a study performed in Cali, Colombia, using this method obtained 84.6% sensitivity for PCR compared to traditional methods.
We consider it possible that the oligonucleotide primers B1/B2 may not detect DNA of all the species belonging to the complex or its variants. These primers were design based on a fragment of 208 bp of the minicircle of kDNA common to the species L. (V.) The use of primers B1/B2 has not previously been reported in formalin fixed and paraffin embedded tissues samples. However, because of the results obtained by the PCR genus-specific we can exclude the possibility of PCR inhibition. The latter detected Leishmania DNA in all the histopathologic positive samples for cutaneous leishmaniasis. Furthermore, the negative control gave a negative 
